• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

2014-15,Profits down another 39%

Anonymous

Guest
This on top of the 28%profit loss the year before.With sh## products and 4500 more Actos lawsuits,this company is dead in the water,but will squeeze every last buck,any way it can,at anyone's expense,along the way!Integrity and scruples do not exist here anymore.Good luck to those that choose to ignore the signs!Hope the koo-aid is tasty!
 

<







That's not kool-ade they are slurping down. Just wait till the profit numbers come in on Contrave. 900 reps and can't beat the competitors even by taking a loss on the product. With all the lawsuits, Takeda can't survive much longer.
 




That's not kool-ade they are slurping down. Just wait till the profit numbers come in on Contrave. 900 reps and can't beat the competitors even by taking a loss on the product. With all the lawsuits, Takeda can't survive much longer.

Not with the buffoons running it now!My thoughts and prayers go out to the many good people who will be affected by these jokers!